IVS

What IVS does

IVS is a private, for-profit healthcare services firm headquartered in Manchester, United Kingdom, founded in 1999. The firm operates across four interrelated clinical service lines: vascular services, core laboratory services, clinical research, and diagnostic and treatment services. This positioning places IVS in the UK private clinical services market, likely serving a mix of NHS referrals, private hospitals, and potentially pharmaceutical or biotechnology sponsors requiring core lab and research capabilities.

The company operates with a headcount of 101-250 employees, consistent with a mid-sized specialist clinical services provider rather than a niche boutique or large diversified group. Andrew Picton serves as Managing Director. Beyond this leadership data, the source material is limited: the company's primary website (ivs-online.co.uk) returned only a loading/verification screen with no substantive product, pricing, technology, or commercial detail extractable. As a result, the underlying technology stack, proprietary platforms, contract structures, and customer mix cannot be characterized from the available data.

The business model is presumed to be fee-for-service across its clinical lines — diagnostic imaging/treatment billing, core lab analytical services, and research study execution — typical of UK private clinical service providers, but no pricing model, GTM motion, or revenue mechanics are confirmed in the input. IVS has operated continuously for over 25 years without disclosed funding events or M&A activity in the available data, indicating a stable, privately-held operating profile.

Name

IVS

Website

https://ivs-online.co.uk

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

101–250 employees

Short description

IVS is a UK-based, privately held healthcare firm in Manchester that provides vascular, core laboratory, research, and diagnostic and treatment services to clinical and research customers.

Ownership category

akta.pro rank

Product category

Healthcare Diagnostic Services

NAICS

Medical and Diagnostic Laboratories (62151), Ambulatory Health Care Services (621)

SIC

Services-Medical Laboratories (8071), Services-Health Services (8000)

akta.pro primary industry

Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics) (HLAHAAAN)

akta.pro secondary industries

IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM), Infusion Pumps (Ambulatory/Stationary) (HLAHAIAF)

Keywords

• Vascular diagnostics
• Core lab services
• Medical research support
• Healthcare diagnostics
• Treatment services

Headquarters

HQ city

Manchester

HQ country

United Kingdom

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Core offering

IVS is a healthcare firm that provides vascular, core laboratory, research, and diagnostic and treatment services. It serves healthcare and research customers requiring clinical diagnostic and laboratory support capabilities from its Manchester, UK base.

Product overview

No product information available. The source page displayed a loading/verification screen ("One moment, please...") with no substantive company content.

Differentiator

Problem solved

Functional benefit

Products and services

• Vascular Services

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves3 records

Expansion highlights2 records

Direct peers

• Medpace Holdings: Mid-to-large CRO focused on clinical development services for smaller and mid-sized biopharma sponsors. Comparable to IVS as a clinical research services provider, though Medpace operates at substantially greater scale with global reach.
• ICON plc: Global CRO and central laboratory services provider offering clinical research, bioanalytical, and lab services to pharma/biotech sponsors. Most directly comparable to IVS on the 'core lab + research services' positioning, though at vastly larger scale.
• Charles River Laboratories: Provides research and laboratory services spanning preclinical, central lab, and clinical trial support. Closely comparable to IVS in combining a core lab capability with broader research services for life-science sponsors.
• Syneos Health: Biopharmaceutical services organization offering clinical research and related laboratory/consulting services. Comparable to IVS as a clinical research services platform serving pharma/biotech sponsors.
• Labcorp: Major clinical laboratory operator with a dedicated central-lab and early-development research services arm (formerly Covance). Directly comparable to IVS in core lab and diagnostic testing services for both clinical-trial and routine-care use cases.

Broad incumbents

• Eurofins Scientific: Global testing laboratory group with extensive clinical-diagnostics, pharma-services, and central-lab capabilities. Overlaps with IVS's core lab and diagnostic services lines, but at multi-billion euro scale across many end markets.
• IQVIA: Largest global CRO with integrated central laboratory, technology, and data-analytics services. Comparable to IVS across lab, research, and broader clinical services, but at incumbent global scale spanning every major geography.

Emerging players

• Bio-Techne: Provides research reagents, assay kits, and diagnostic tools used in clinical and research laboratories. Comparable to IVS on the diagnostic/reagents side of lab services, with a stronger product focus and US listing.
• Frontier Scientific Services (Frontage): CRO offering central laboratory, bioanalytical, and clinical research services to pharma and biotech. Comparable to IVS as a mid-sized services provider with central-lab focus, though with a stronger US/China footprint.

Regional players

• WuXi AppTec: China-based CRO/CDMO with extensive central-lab and clinical research capabilities. Comparable to IVS on lab and clinical research services, but operates primarily in Asia-Pacific and US markets rather than the UK.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/independent-vascular-services-limited

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IVS